Cargando…
泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119723/ https://www.ncbi.nlm.nih.gov/pubmed/37356991 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.03.015 |
| _version_ | 1785029064590884864 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10119723 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101197232023-04-22 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 Zhonghua Xue Ye Xue Za Zhi 病例报告 Editorial office of Chinese Journal of Hematology 2023-03 /pmc/articles/PMC10119723/ /pubmed/37356991 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.03.015 Text en 2023年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 病例报告 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title | 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title_full | 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title_fullStr | 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title_full_unstemmed | 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title_short | 泽布替尼联合利妥昔单抗治疗伴CD79B及MYD88突变的原发皮肤弥漫大B细胞淋巴瘤，腿型1例 |
| title_sort | 泽布替尼联合利妥昔单抗治疗伴cd79b及myd88突变的原发皮肤弥漫大b细胞淋巴瘤，腿型1例 |
| topic | 病例报告 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119723/ https://www.ncbi.nlm.nih.gov/pubmed/37356991 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.03.015 |
| work_keys_str_mv | AT zébùtìníliánhélìtuǒxīdānkàngzhìliáobàncd79bjímyd88tūbiàndeyuánfāpífūmímàndàbxìbāolínbāliútuǐxíng1lì AT zébùtìníliánhélìtuǒxīdānkàngzhìliáobàncd79bjímyd88tūbiàndeyuánfāpífūmímàndàbxìbāolínbāliútuǐxíng1lì AT zébùtìníliánhélìtuǒxīdānkàngzhìliáobàncd79bjímyd88tūbiàndeyuánfāpífūmímàndàbxìbāolínbāliútuǐxíng1lì AT zébùtìníliánhélìtuǒxīdānkàngzhìliáobàncd79bjímyd88tūbiàndeyuánfāpífūmímàndàbxìbāolínbāliútuǐxíng1lì |